Gene editing helped chemotherapy reach brain tumors in mice
Original title: Genomic Deletion of P-Glycoprotein from Gliomas Via the Focused Ultrasound-Delivery of a Duplex CRISPR Cas9 Ribonucleoprotein System.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in mice.
The short version
In mice, switching off a drug pump helped a cancer drug work better in brain tumors.
What was studied. Researchers tested gene editing tools in mice with brain tumors called gliomas. The goal was to shut off a pump named P-glycoprotein, which pushes drugs back out of tumor cells and blood vessels.
What they found. The tools blocked the pump in both tumor cells and blood vessels. The tumors then responded better to paclitaxel, a chemotherapy drug that the pump normally pushes out. This worked when the tools were placed straight into the tumor, and also when tiny fat bubbles carried them through the blood and sound waves aimed them at the brain.
What this means, and what it doesn't
What it could mean: One reason many drugs fail in brain tumors is that they get pushed out. This study points to a possible way to stop that. If it holds up, some drugs that do not work today might work better later.
What it doesn't mean: This does not mean a new treatment is ready for people. The work was done in mice only, and the authors call it a concept. It has not been tested for safety in humans. It is not a cure and not a promise of one. Years more work would be needed before any patient could get this.
Source: PubMed, July 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.